Related Experiment Video
Updated: Sep 24, 2025

07:35
Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
Published on: October 11, 2018
7.7K
BioTransformer 3.0-a web server for accurately predicting metabolic transformation products
David S Wishart1,2,3,4,5, Siyang Tian1, Dana Allen1
1Department of Biological Sciences, University of Alberta, Edmonton, AB T6G 2E9, Canada.
Nucleic Acids Research
|May 10, 2022
Summary
BioTransformer 3.0 predicts small-molecule metabolism in humans and the environment using advanced machine learning and rule-based systems. This tool enhances accuracy and comprehensiveness for both xenobiotic and endogenous metabolite transformations.
Area of Science:
- Computational chemistry and cheminformatics
- Drug metabolism and pharmacokinetics
- Environmental chemistry
Background:
- Accurate prediction of small-molecule metabolism is crucial for drug development and environmental risk assessment.
- Previous versions of BioTransformer had limitations in scope and accuracy for predicting metabolic transformation products.
- There is a need for comprehensive in silico tools that can handle both exogenous and endogenous compounds.
Purpose of the Study:
- To introduce BioTransformer 3.0, an enhanced web server for in silico metabolism prediction.
- To improve the accuracy, speed, and comprehensiveness of small-molecule metabolism prediction.
- To extend prediction capabilities to endogenous metabolites and environmental microbiota.
Main Methods:
- Integration of machine learning approaches with a refined rule-based system.
- Inclusion of new databases, constraints, and prediction modules.
- Support for customized sequential transformations and multi-step simulations.
Main Results:
- BioTransformer 3.0 achieves 40-50% higher accuracy compared to previous versions.
- The system demonstrates reduced susceptibility to combinatorial 'explosions'.
- Expanded metabolite coverage and prediction capabilities for both xenobiotics and endogenous compounds.
Conclusions:
- BioTransformer 3.0 provides a powerful and accurate platform for in silico metabolism prediction.
- The enhanced capabilities facilitate a deeper understanding of xenobiotic and endogenous compound biotransformation.
- This tool supports research in drug discovery, environmental science, and toxicology.
Related Concept Videos
Drug Biotransformation: Overview
3.0K
Pharmaceutical substances known as xenobiotics are predominantly lipophilic and nonionized. This enables them to permeate lipid bilayers, such as cell membranes, and interact with intracellular target receptors. Lipophilic drugs have an advantage in crossing biological barriers and reaching their intended sites of action. However, lipophilic drugs often have a restricted capacity for renal expulsion or elimination from the body. When these drugs enter the kidneys and undergo glomerular...
3.0K
Metabolism of Chemolithotrophs
222
Chemolithotrophs are microorganisms that obtain energy by oxidizing inorganic molecules such as hydrogen gas (H₂), ammonia (NH₃), reduced sulfur compounds (H₂S, S²⁻), and ferrous iron (Fe²⁺). Unlike heterotrophic organisms that rely on organic carbon, chemolithotrophs transfer electrons from these inorganic donors to the electron transport chain (ETC), generating a proton motive force (PMF) that drives ATP synthesis through oxidative phosphorylation.
222

